Sumitomo Life Insurance Co. Purchases 72 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Sumitomo Life Insurance Co. lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,291 shares of the company’s stock after buying an additional 72 shares during the quarter. Sumitomo Life Insurance Co.’s holdings in HCA Healthcare were worth $931,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in HCA. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new position in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC purchased a new stake in shares of HCA Healthcare during the 2nd quarter worth $28,000. GPS Wealth Strategies Group LLC grew its stake in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. purchased a new stake in shares of HCA Healthcare during the second quarter valued at about $33,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $409.23 on Thursday. The firm’s 50 day simple moving average is $390.17 and its 200-day simple moving average is $349.03. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $416.72. The stock has a market capitalization of $107.18 billion, a price-to-earnings ratio of 20.40, a PEG ratio of 1.44 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the prior year, the company posted $4.29 EPS. Analysts expect that HCA Healthcare, Inc. will post 22.51 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were paid a $0.66 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $2.64 dividend on an annualized basis and a yield of 0.65%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

Wall Street Analyst Weigh In

Several research firms recently commented on HCA. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Royal Bank of Canada boosted their target price on HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. UBS Group raised their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a report on Wednesday, August 14th. Leerink Partners increased their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Finally, Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $365.65.

Insider Buying and Selling at HCA Healthcare

In related news, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at $14,569,729.80. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the company’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock valued at $6,407,273 over the last ninety days. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.